Lv2
110 积分 2025-10-16 加入
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
2个月前
已完结
Effect of Intensive Urate Lowering With Combined Verinurad and Febuxostat on Albuminuria in Patients With Type 2 Diabetes: A Randomized Trial
2个月前
已完结
Evolving understanding of cardiovascular protection by SGLT2 inhibitors: focus on renal protection, myocardial effects, uric acid, and magnesium balance
2个月前
已完结
SGLT2 Inhibitors and Kidney Outcomes by Glomerular Filtration Rate and Albuminuria
2个月前
已完结
Effects of sodium-glucose cotransporter-2 (SGLT-2) inhibitors on serum uric acid levels in patients with chronic kidney disease: a systematic review and network meta-analysis
2个月前
已关闭
Empagliflozin lowers serum uric acid in chronic kidney disease: exploratory analyses from the EMPA-KIDNEY trial
2个月前
已关闭
The Gut Microbiome in Hyperuricemia and Gout
2个月前
已完结
Reducing hyperuricemic events with SGLT2 inhibitors: An updated systematic review with meta-regression
3个月前
已完结
Serum urate change among gout patients treated with sodium-glucose cotransporter type 2 inhibitors vs. sulfonylurea: A comparative effectiveness analysis
3个月前
已完结
Losartan and dapagliflozin combination therapy in reducing uric acid level compared to monotherapy in patients with heart failure
3个月前
已关闭
皖公网安备34019202002308
